Recalls / Active ingredient / Infliximab
Infliximab
1 FDA drug recall involving the active ingredient “Infliximab”.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2025-01-17 | Class II | Inflectra (infliximab-dyyb), For injection, 100mg per vial, packaged in 10 mL single-dose vial, Rx only, Mfd b | McKesson |